Both Akt and mTOR are two important PI3K targets that are frequently activated in human primary prostate cancer specimens, as evidenced by increased phosphorylation of both Akt and S6RP, a downstream target of mTOR (64, 65). This evidence concerns the gene MTOR and prostate cancer.